172
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Analysis of Parafoveal Microvascular Abnormalities in Behcet’s Uveitis Using Projection-Resolved Optical Coherence Tomographic Angiography

, MD, , MD, , MD, , BS, , MD, , BS & , MD show all
Pages 524-529 | Received 15 Dec 2018, Accepted 22 Oct 2019, Published online: 19 Nov 2019

References

  • Al-Otaibi LM, Porter SR, Poate TW. Behcet’s disease: a review. J Dent Res. 2005;84:209–222.
  • Deuter CM, Kotter I, Wallace GR, et al. Behcet’s disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27(1):111–136.
  • Coscas F, Glacet-Bernard A, Miere A, et al. Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Am J Ophthalmol. 2016;161:160–71.e1-2.
  • Kim AY, Chu Z, Shahidzadeh A, et al. Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(9):OCT362–70.
  • Rao HL, Pradhan ZS, Weinreb RN, et al. Determinants of peripapillary and macular vessel densities measured by optical coherence tomography angiography in normal eyes. J Glaucoma. 2017;26(5):491–497.
  • Cheng D, Shen M, Zhuang X, et al. Inner retinal microvasculature damage correlates with outer retinal disruption during remission in Behcet’s posterior uveitis by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2018;59(3):1295–1304.
  • Somkijrungroj T, Vongkulsiri S, Kongwattananon W, et al. Assessment of vascular change using swept-source optical coherence tomography angiography: a new theory explains central visual loss in Behcet’s disease. J Ophthalmol. 2017;2017:2180723.
  • Khairallah M, Abroug N, Khochtali S, et al. Optical coherence tomography angiography in patients with Behcet uveitis. Retina. 2017;37(9):1678–1691.
  • Liu L, Jian G, Bao W, et al. Analysis of foveal microvascular abnormalities in diabetic retinopathy using optical coherence tomography angiography with projection artifact removal. J Ophthalmol. 2018;2018:3926745.
  • Bhavsar KV, Jia Y, Wang J, et al. Projection-resolved optical coherence tomography angiography exhibiting early flow prior to clinically observed retinal angiomatous proliferation. Am J Ophthalmol Case Rep. 2017;8:53–57.
  • Zhang M, Hwang TS, Campbell JP, et al. Projection-resolved optical coherence tomographic angiography. Biomed Opt Express. 2016;7(3):816.
  • Criteria for diagnosis of Behcet’s disease. International study group for Behcet’s disease. Lancet. 1990;335(8697): 1078–1080.
  • Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13:388–391.
  • Pei M, Liu X, Zhao C, et al. Chemokine and adhesion molecule profiles in aqueous humor of clinically quiescent Uveitic cataracts. Curr Eye Res. 2019;44(2):194–199.x
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
  • Kuehlewein L, Tepelus TC, An L, et al. Noninvasive visualization and analysis of the human parafoveal capillary network using swept source OCT optical microangiography. Invest Ophthalmol Vis Sci. 2015;56(6):3984–3988.
  • Shahlaee A, Pefkianaki M, Hsu J, Ho AC. Measurement of foveal avascular zone dimensions and its reliability in healthy eyes using optical coherence tomography angiography. Am J Ophthalmol. 2016;161:50–5.e1.
  • Yan H, Li J, Zhang J, Yang L. Retinal and choroidal thickness in patients with Uveitis. Ocul Immunol Inflamm. 2017;25:202–209.
  • Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82(1):60–76.
  • Kim M, Kim H, Kwon HJ, et al. Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci. 2013;54(9):6033–6039.
  • Takase N, Nozaki M, Kato A, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by EN face optical coherence tomography angiography. Retina. 2015;35(11):2377–2383.
  • Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol. 2015;160(1):35–44.e1.
  • Bradley PD, Sim DA, Keane PA, et al. The evaluation of diabetic macular ischemia using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(2):626–631.
  • van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006;22:503–508.
  • Schwartz MM, Kawala KS, Corwin HL, Lewis EJ. The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. Kidney Int. 1987;32:274–279.
  • Sundy JS, Haynes BF. Pathogenic mechanisms of vessel damage in vasculitis syndromes. Rheum Dis Clin North Am. 1995;21:861–881.
  • Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med. 1998;3:21–28.
  • Assar ME, Angulo J, Rodriguez-Manas L. Diabetes and ageing-induced vascular inflammation. J Physiol. 2016;594:2125–2146.
  • Dollery CT, Bulpitt CJ, Kohner EM. Oxygen supply to the retina from the retinal and choroidal circulations at normal and increased arterial oxygen tensions. Invest Ophthalmol. 1969;8:588–594.
  • McGarry T, Biniecka M, Veale DJ, Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic Biol Med. 2018;125:15–24.
  • Cringle SJ, Yu DY. A multi-layer model of retinal oxygen supply and consumption helps explain the muted rise in inner retinal PO(2) during systemic hyperoxia. Comp Biochem Physiol A Mol Integr Physiol. 2002;132:61–66.
  • Triolo G, Vadala M, Accardo-Palumbo A, et al. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet’s disease. Ann Rheum Dis. 2002;61(6):560–561.
  • Sadreddini S, Noshad H, Molaeefard M, Noshad R. Treatment of retinal vasculitis in Behcet’s disease with rituximab. Mod Rheumatol. 2008;18:306–308.
  • Probst K, Fijnheer R, Rothova A. Endothelial cell activation and hypercoagulability in ocular Behcet’s disease. Am J Ophthalmol. 2004;137:850–857.
  • Mesquida M, Molins B, Llorenc V, et al. Proinflammatory cytokines and C-reactive protein in uveitis associated with Behcet’s disease. Mediators Inflamm. 2014;2014:396204.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.